Skip to main content
Caplight Logo









Bottneuro AG

Bottneuro AG

Private
BaselHealthcare & Life Scienceshttps://bottneuro.ch/

Last Round

Grant

Apr 8, 2026

Total Funding Raised

$160,000

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Bottneuro AG is a neurotech company that develops non-invasive, personalized neuromodulation therapies and diagnostic solutions for patients with neurological conditions such as Alzheimer's disease.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Hardware + Subscription, Hardware Sales

AI Layer

Application

Keywords

neurostimulationAlzheimer's treatmentmedical deviceprecision medicinebrain stimulationneurodegenerative diseasedigital healthmedtechwearable medical devicenon-invasive therapyclinical AIbrain mappinghome-based carebioelectronic medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Bottneuro AG Comparables

Compare Bottneuro AG with similar companies based on industry and business-model similarity.

Bottneuro AG comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Sinaptica Therapeutics
84%
REGEnLIFE
81%
Neurocia SAS
79%

Bottneuro AG Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantApr 8, 2026
VC RoundDec 15, 2022
GrantDec 17, 2021
SeedNov 1, 2021

Key People

Founding team and executive leadership

Bekim Osmani

Chairman & Group CEO

Executive Team

Bottneuro AG Investors

Notable investors and investment history

Bottneuro AG investors
InvestorRounds
KickfundSeed
DART VenturesVC Round
Venture KickGrant
InnosuisseGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 8, 2026

    Received grant funding from Innosuisse.

  • Apr 6, 2026

    Monthly visitors grew 982% MoM, reaching 1.6K.

Bottneuro AG Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Bottneuro AG Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Bottneuro AG's valuation, stock price, and market status.

Firmographic Details

HeadquartersBasel
Employee Range11
Year Founded2021
Last FundingApr 8, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?